A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/107 (2006.01) A61K 9/48 (2006.01)
Patent
CA 2671495
A drug delivery system, e.g., microemulsion preconcentrate, that spontaneously forms a microemulsion when brought in contact with an aqueous medium. The drug delivery system contains valsartan, a hydrophilic component, a lipophilic component and a surfactant. A particularly useful hydrophilic component in the system is a polymer that is solid at room temperature, e.g., solid PEG.
L'invention concerne un système d'administration de médicament, par exemple, un préconcentré de microémulsion, qui forme spontanément une microémulsion lorsque amené au contact d'un milieu aqueux. Le système d'administration de médicament contient du valsartan, un composé hydrophile, un composé lipophile et un agent tensioactif. Un polymère soluble à température ambiante, par exemple du PEG soluble, constitue un composé lipophile particulièrement utile dans le système.
Joshi Yatindra
Kennedy John Joseph
Li Ping
Royce Alan Edward
Wagner Robert Frank
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Microemulsion dosage forms of valsartan and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microemulsion dosage forms of valsartan and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microemulsion dosage forms of valsartan and methods of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1517529